As the 2024 US presidential election approaches, speculation about Kamala Harris potentially stepping into the Oval Office remains strong.  Despite Donald Trump's assertion that Harris would be an ea
Continued solid uptake of Organon's (OGN) products is expected to have driven second-quarter revenues.
Besides Wall Street's top -and-bottom-line estimates for Organon (OGN), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the qua
In the latest trading session, Organon (OGN) closed at $21.86, marking a -1.84% move from the previous day.
Organon (OGN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Organon stock experienced significant downside pressure in 2023, however positive Q423 and Q124 earnings have led to a bull run. Organon's business includes women's health, biosimilars, and establishe
The Zacks Medical - Services industry is growing on nursing care market growth and digital healthcare adoption. ICLR, OGN and DOCS are set to gain the most.
Organon (OGN) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Recently, Zacks.com users have been paying close attention to Organon (OGN). This makes it worthwhile to examine what the stock has in store.
Last week's action in the stock market might have signaled a long-awaited shift away from a focus on Big Tech in the stock market to overlooked pockets of value.
In the closing of the recent trading day, Organon (OGN) stood at $20.81, denoting a +0.39% change from the preceding trading day.
In the most recent trading session, Organon (OGN) closed at $19.93, indicating a -1.04% shift from the previous trading day.
JERSEY CITY, N.J.--(BUSINESS WIRE)--Organon will report Q2 2024 results and host conference call on August 6, 2024. Organon estimates $15M milestone expenses in second quarter.
In the most recent trading session, Organon (OGN) closed at $20.63, indicating a -0.77% shift from the previous trading day.
Volatility has increased on Wall Street while tech stocks are taking a breather. As a result, many investors are eyeing value stocks to buy, which may hold considerable potential for future returns.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE